When lower price playing cards might help alleviate the burden of substantial drug charges in the temporary, they don't address the systemic difficulties driving up prescription rates inside the U.S. Broader coverage modifications could tackle the root causes of growing drug costs, including insufficient transparency in pricing as well as the role